Skip to main content


Please see below links to the most recent news and events for IDEAYA.


Media Contacts News Alerts LinkedIn

Latest Press
Sep 11, 2023

Initiated IDE161 Phase 1 expansion based on preliminary tumor shrinkage observed in multiple HRD solid tumor patients, including an endometrial cancer subject with a first imaging assessment of a...

Sep 5, 2023

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in upcoming investor...

Aug 21, 2023

GSK101 (IDE705) is being developed as a potential first-in-class Pol Theta Helicase Inhibitor in combination with niraparib in GSK-sponsored Phase 1/2 clinical trial GSK101 and niraparib...

All News

Featured Stories
Stay up-to-date with us
* Required Fields
Close Menu